Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
national top stories
4
×
biotech
boston blog main
san francisco blog main
boston
boston top stories
enzyme
gene editing
san francisco top stories
agios therapeutics
akili interactive labs
base editing
biopharma
branden moriarty
broad institute
bruce leuchter
cas13
click therapeutics
clickotine
clinical study
crispr therapeutics
crispr-cas9
data
david benshoof klein
david klein
david liu
deals
digital health
digital medicines
digital therapeutics
disease
dna
duchenne
editas medicine
editor
editr
europe blog main
europe top stories
What
medicine
4
×
therapeutics
4
×
gene
editing
announced
approval
backs
beam
benefit
bets
betting
billion
biopharma
cas
click
crispr
deal
digital
drug
duchenne
editas
editor
example
fda
field
founders
gain
going
gotten
grabbed
harvard
historic
humans
isn't
jump
landmark
latest
little
makers
making
Language
unset
Current search:
therapeutics
×
medicine
×
" national top stories "
×
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
5 years ago
In Landmark Gene-Editing Study, Sangamo Reports Little Benefit
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
Beam Therapeutics Spotlights CRISPR 2.0 with Precise Gene Editor, $87M